Exact Mass: 500.2105
Exact Mass Matches: 500.2105
Found 500 metabolites which its exact mass value is equals to given mass value 500.2105
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Austin
Austin is a mycotoxin produced by the food storage mould (Aspergillus ustus). These are sesquiterpenes containing a lactone ring. Mycotoxin production by the food storage mould (Aspergillus ustus).
Tritoqualine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists Tritoqualine is an H1-antihistamine. C471 - Enzyme Inhibitor
D-Phenylalanyl-N-[(3s)-6-Carbamimidamido-1-Chloro-2-Oxohexan-3-Yl]-L-Phenylalaninamide
Phenylalanyl-phenylalanyl-arginine chloromethyl ketone
Galactoarabinan
L-Tyrosine, N-(2-(methoxycarbonyl)phenyl)-O-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-
Rolapitant
2-((Z)-hepta-5-en-1,3-diynyl)tetrahydrofuran-2-beta-D-glucopyranosyl(1->2)-beta-D-glucopyranoside|panaxfurayne B
Orbiculin D
A dihydroagarofuran sesquiterpenoid that consists of dihydro-beta-agarofuran substituted by acetoxy group at position 1 and furoyloxy groups at positions 6 and 9 (the 1beta,6alpha,9alpha stereoisomer). Isolated from Celastrus orbiculatus, it exhibits inhibition of both NF-kappaB activation and nitric oxide production.
(3S)-3,7-anhydro-6,7-dehydroericanone 4-beta-D-glucopyranoside
(1R,4S,5R,6R,7R,8R)-3-Oxo-8-<5-(5-acetoxytiglyloxy)-tiglyloxy>-guaia-10(14),11(13)-dien-6,12-olide|(1R,4S,5R,6R,7R,8R)-3-Oxo-8-[5-(5-acetoxytiglyloxy)-tiglyloxy]-guaia-10(14),11(13)-dien-6,12-olide
O-Rutinoside-3-(3-Hydroxypropyl)phthalide|Pedirutinoside
Dodoviscin A
dodoviscin A is a natural product found in Dodonaea viscosa with data available.
cipatrijugin G|methyl rel-[(4R,4aS,6R,7aR,8S,11aS,12aR)-4-(furan-3-yl)dodecahydro-6-hydroxy-4a,7a,9,9-tetramethyl-13-methylidene-2,7,10-trioxo-4H-6,12a-methanopyrano[4,3-b][1]benzoxocin-8-yl]acetate
(1R,2S,4S,5S,6R,7R,9S,10S)-1,2,9,15-tetraacetoxy-4,6-dihydroxy-8-oxodihydro-beta-agarofuran
Dodovisone B
Tritoqualine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C471 - Enzyme Inhibitor
Ala Phe Thr Tyr
Ala Phe Tyr Thr
Ala His His His
Ala Thr Phe Tyr
Ala Thr Tyr Phe
Ala Tyr Phe Thr
Ala Tyr Thr Phe
Cys Glu His Ile
Cys Glu His Leu
Cys Glu Ile His
Cys Glu Leu His
Cys His Glu Ile
Cys His Glu Leu
Cys His Ile Glu
Cys His Lys Asn
Cys His Leu Glu
Cys His Asn Lys
Cys Ile Glu His
Cys Ile His Glu
Cys Lys His Asn
Cys Lys Asn His
Cys Leu Glu His
Cys Leu His Glu
Cys Asn His Lys
Cys Asn Lys His
Asp Phe Gly Tyr
Asp Phe Tyr Gly
Asp Gly Phe Tyr
Asp Gly Tyr Phe
Asp His Glu Thr
Asp His Met Val
Asp His Thr Glu
Asp His Val Met
Asp Met His Val
Asp Met Val His
Asp Asn Pro Arg
Asp Asn Arg Pro
Asp Pro Asn Arg
Asp Pro Arg Asn
Asp Arg Asn Pro
Asp Arg Pro Asn
Asp Thr Glu His
Asp Thr His Glu
Asp Val His Met
Asp Val Met His
Asp Tyr Phe Gly
Asp Tyr Gly Phe
Glu Cys His Ile
Glu Cys His Leu
Glu Cys Ile His
Glu Cys Leu His
Glu Asp His Thr
Glu Asp Thr His
Glu Glu His Ser
Glu Glu Ser His
Glu His Cys Ile
Glu His Cys Leu
Glu His Asp Thr
Glu His Glu Ser
Glu His Ile Cys
Glu His Leu Cys
Glu His Ser Glu
Glu His Thr Asp
Glu Ile Cys His
Glu Ile His Cys
Glu Leu Cys His
Glu Leu His Cys
Glu Pro Gln Gln
Glu Gln Pro Gln
Glu Gln Gln Pro
Glu Ser Glu His
Glu Ser His Glu
Glu Thr Asp His
Glu Thr His Asp
Phe Ala Thr Tyr
Phe Ala Tyr Thr
Phe Asp Gly Tyr
Phe Asp Tyr Gly
Phe Phe Gly Met
Phe Phe Met Gly
Phe Phe Ser Thr
Phe Phe Thr Ser
Phe Gly Asp Tyr
Phe Gly Phe Met
Phe Gly Met Phe
Phe Gly Tyr Asp
Phe Met Phe Gly
Phe Met Gly Phe
Phe Ser Phe Thr
Phe Ser Thr Phe
Phe Thr Ala Tyr
Phe Thr Phe Ser
Phe Thr Ser Phe
Phe Thr Tyr Ala
Phe Tyr Ala Thr
Phe Tyr Asp Gly
Phe Tyr Gly Asp
Phe Tyr Thr Ala
Gly Asp Phe Tyr
Gly Asp Tyr Phe
Gly Phe Asp Tyr
Gly Phe Phe Met
Gly Phe Met Phe
Gly Phe Tyr Asp
Gly Met Phe Phe
Gly Val Tyr Tyr
Gly Tyr Asp Phe
Gly Tyr Phe Asp
Gly Tyr Val Tyr
Gly Tyr Tyr Val
His Ala His His
His Cys Glu Ile
His Cys Glu Leu
His Cys Ile Glu
His Cys Lys Asn
His Cys Leu Glu
His Cys Asn Lys
His Asp Glu Thr
His Asp Met Val
His Asp Thr Glu
His Asp Val Met
His Glu Cys Ile
His Glu Cys Leu
His Glu Asp Thr
His Glu Glu Ser
His Glu Ile Cys
His Glu Leu Cys
His Glu Thr Asp
His His Ala His
His His His Ala
His Ile Cys Glu
His Ile Glu Cys
His Lys Cys Asn
His Lys Asn Cys
His Leu Cys Glu
His Leu Glu Cys
His Met Asp Val
His Met Val Asp
His Asn Cys Lys
His Asn Lys Cys
His Ser Glu Glu
His Thr Asp Glu
His Thr Glu Asp
His Val Asp Met
His Val Met Asp
Ile Cys Glu His
Ile Cys His Glu
Ile Glu Cys His
Ile Glu His Cys
Ile His Cys Glu
Ile His Glu Cys
Lys Cys His Asn
Lys Cys Asn His
Lys His Cys Asn
Lys His Asn Cys
Lys Asn Cys His
Lys Asn His Cys
Leu Cys Glu His
Leu Cys His Glu
Leu Glu Cys His
Leu Glu His Cys
Leu His Cys Glu
Leu His Glu Cys
Met Asp His Val
Met Asp Val His
Met Phe Phe Gly
Met Phe Gly Phe
Met Gly Phe Phe
Met His Asp Val
Met His Val Asp
Met Ser Thr Tyr
Met Ser Tyr Thr
Met Thr Ser Tyr
Met Thr Tyr Ser
Met Val Asp His
Met Val His Asp
Met Tyr Ser Thr
Met Tyr Thr Ser
Asn Cys His Lys
Asn Cys Lys His
Asn Asp Pro Arg
Asn Asp Arg Pro
Asn His Cys Lys
Asn His Lys Cys
Asn Lys Cys His
Asn Lys His Cys
Asn Pro Asp Arg
Asn Pro Arg Asp
Asn Arg Asp Pro
Asn Arg Pro Asp
Pro Asp Asn Arg
Pro Asp Arg Asn
Pro Glu Gln Gln
Pro Asn Asp Arg
Pro Asn Arg Asp
Pro Gln Glu Gln
Pro Gln Gln Glu
Pro Arg Asp Asn
Pro Arg Asn Asp
Gln Glu Pro Gln
Gln Glu Gln Pro
Gln Pro Glu Gln
Gln Pro Gln Glu
Gln Gln Glu Pro
Gln Gln Pro Glu
Arg Asp Asn Pro
Arg Asp Pro Asn
Arg Asn Asp Pro
Arg Asn Pro Asp
Arg Pro Asp Asn
Arg Pro Asn Asp
Ser Glu Glu His
Ser Glu His Glu
Ser Phe Phe Thr
Ser Phe Thr Phe
Ser His Glu Glu
Ser Met Thr Tyr
Ser Met Tyr Thr
Ser Thr Phe Phe
Ser Thr Met Tyr
Ser Thr Tyr Met
Ser Tyr Met Thr
Ser Tyr Thr Met
Thr Ala Phe Tyr
Thr Ala Tyr Phe
Thr Asp Glu His
Thr Asp His Glu
Thr Glu Asp His
Thr Glu His Asp
Thr Phe Ala Tyr
Thr Phe Phe Ser
Thr Phe Ser Phe
Thr Phe Tyr Ala
Thr His Asp Glu
Thr His Glu Asp
Thr Met Ser Tyr
Thr Met Tyr Ser
Thr Ser Phe Phe
Thr Ser Met Tyr
Thr Ser Tyr Met
Thr Tyr Ala Phe
Thr Tyr Phe Ala
Thr Tyr Met Ser
Thr Tyr Ser Met
Val Asp His Met
Val Asp Met His
Val Gly Tyr Tyr
Val His Asp Met
Val His Met Asp
Val Met Asp His
Val Met His Asp
Val Tyr Gly Tyr
Val Tyr Tyr Gly
Tyr Ala Phe Thr
Tyr Ala Thr Phe
Tyr Asp Phe Gly
Tyr Asp Gly Phe
Tyr Phe Ala Thr
Tyr Phe Asp Gly
Tyr Phe Gly Asp
Tyr Phe Thr Ala
Tyr Gly Asp Phe
Tyr Gly Phe Asp
Tyr Gly Val Tyr
Tyr Gly Tyr Val
Tyr Met Ser Thr
Tyr Met Thr Ser
Tyr Ser Met Thr
Tyr Ser Thr Met
Tyr Thr Ala Phe
Tyr Thr Phe Ala
Tyr Thr Met Ser
Tyr Thr Ser Met
Tyr Val Gly Tyr
Tyr Val Tyr Gly
Tyr Tyr Gly Val
Tyr Tyr Val Gly
punaglandin 6
punaglandin 6
rolapitant
A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Rolapitant (SCH619734) is a potent, selective, long-acting and orally active neurokinin 1 (NK1) receptor antagonist with a Ki of 0.66 nM. Rolapitant does not interact with CYP3A4. Rolapitant shows potent anti-emetic activity in a ferret emesis model[1][2].
Dovitinib lactate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
β-Alanine, N-[[2-[[[4-(aminocarbonyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester
H-D-Phe-Phe-Arg-chloromethylketone trifluoroacetate salt
(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide
C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent
(1S,3S)-3-ethyl-3,5,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-azaniumyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(2S)-3-hydroxy-2-[[1-[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]piperidine-1-carbonyl]oxymethyl]pyridin-1-ium-3-carbonyl]amino]propanoic acid
2-amino-N-[2-[[1-chloro-6-(diaminomethylideneamino)-2-oxohexan-3-yl]amino]-3-phenylpropanoyl]-3-phenylpropanamide
(2S)-2-[(4R,5S)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
(2R)-2-[(4S,5R)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5S)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3R)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclohexylacetamide
(1R)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-2-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(2S)-2-[(4S,5R)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(4R,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4S,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(4R,5R)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3S)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3S)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2R,3S)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2R,3R)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2R,3R)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2S,3R)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
N-[[(2R,3S)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide
2-[(3R,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide
(1S)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-2-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
9-(2-Carboxy-4-isothiocyanatophenyl)-3,6-bis(diethylamino)xanthylium
7-amino-4,5,6-triethoxy-3-(9-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-7-yl)-3H-2-benzofuran-1-one
13-deoxycarminomycin(1+)
An anthracyline cation that is the conjugate acid of 13-deoxycarminomycin, obtained by protonation of the amino group. Major microspecies at pH 7.3
ELN-441958
ELN-441958 is a potent, neutral, competitive and selective bradykinin B1 receptor antagonist with a Ki of 0.26 nM against native human bradykinin B1 receptor. ELN-441958 has high oral bioavailability, and has low CNS exposure in the mouse[1].
(1s,2s,3r,7s,8s,9r,13s)-3,8-dimethyl-13-{[(2z)-2-methylbut-2-enoyl]oxy}-12-methylidene-4,11-dioxo-10-oxatricyclo[7.3.1.0³,⁷]tridec-5-en-2-yl (2z)-2-[(acetyloxy)methyl]but-2-enoate
3,9-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl 2-methylbut-2-enoate
12'-hydroxy-2,2,2',6',9',13'-hexamethyl-16'-methylidene-6,11',15'-trioxo-10',14'-dioxaspiro[pyran-3,5'-tetracyclo[7.6.1.0¹,¹².0²,⁷]hexadecan]-6'-en-8'-yl acetate
methyl 2-[6-(furan-3-yl)-11-hydroxy-1,5,15,15-tetramethyl-8,14,17-trioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-9-en-16-yl]-2-hydroxyacetate
(8s,9r,10s)-3,9-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl (2e)-2-methylbut-2-enoate
(6s)-2-[2-(4-hydroxyphenyl)ethyl]-6-[2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]-5,6-dihydropyran-4-one
27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
methyl (2e)-3-[(1s,2r,4s,7s,8s,11r,12s,16r,18r)-7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate
(4r,7r,7ar)-3,7a-dibenzyl-4-hydroxy-4,7-diphenyl-6,7-dihydro-1-benzofuran-2,5-dione
(12'z,18'z,20'z)-6'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
(8r,9r,10r)-9-hydroxy-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl but-2-enoate
2-{3-[(2s)-2,3-dihydroxy-3-methylbutyl]-4-hydroxy-5-(3-methylbut-2-en-1-yl)phenyl}-5,7-dihydroxy-3,6-dimethoxychromen-4-one
3,8-dimethyl-13-[(2-methylbut-2-enoyl)oxy]-12-methylidene-4,11-dioxo-10-oxatricyclo[7.3.1.0³,⁷]tridec-5-en-2-yl 2-[(acetyloxy)methyl]but-2-enoate
(1'r,2s,3'r,8'r,12'e,18'e,20'e,24's,25's,27'r)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
(1'r,2s,3'r,8'r,12'z,18'e,20'z,24's,25's,27'r)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione
15-(2-hydroxy-2-methylpropyl)-4,13,13,18-tetramethyl-12,26-dioxa-4,18-diazahexacyclo[12.12.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-2(11),5,7,9,16(25),19,21,23-octaene-3,17-dione
(1'r,2r,3'r,8'r,13'r,18'e,20'z,24'r,25's)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',12',17',22'-tetrone
methyl (2e)-3-[(1s,2r,4s,7s,8s,11r,12s,16r,18s)-7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate
[(2s,3s,4s,5r)-3,4,5-trihydroxy-6-[(2s)-3-(octanoyloxy)-2-(propanoyloxy)propoxy]oxan-2-yl]methanesulfonic acid
methyl 3-[7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate
methyl 3-[11'-(furan-3-yl)-3'-hydroxy-2',3,3,6',10'-pentamethyl-4',13'-dioxo-12',15'-dioxaspiro[oxirane-2,5'-tetracyclo[8.5.0.0¹,¹⁴.0²,⁷]pentadecan]-6'-yl]prop-2-enoate
13,15-dimethyl (1s,2r,6r,14s,15r,16r,18s,20s)-20-ethoxy-15-hydroxy-11-methoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate
atalantin
{"Ingredient_id": "HBIN017265","Ingredient_name": "atalantin","Alias": "NA","Ingredient_formula": "C27H32O9","Ingredient_Smile": "CC1(C2C(=O)C(C3(C(C2(CO1)C=CC(=O)OC)CCC4(C35C(O5)C(=O)OC4C6=COC=C6)C)C)O)C","Ingredient_weight": "500.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1955","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101593045","DrugBank_id": "NA"}